SCHEMBL4096686

SCHEMBL4096686

Cc1ccn(-c2cccc(C(N)=O)c2F)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.44
RAB9A P51151 2/20 0.44
KDM4E B2RXH2 1/20 0.44
ALDH1A1 P00352 1/20 0.44
GAA P10253 1/20 0.44
TGFBR1 P36897 1/20 0.44
NPC1 O15118 1/20 0.41
ATM Q13315 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
PARP1 P09874 4/20 0.40
TDO2 P48775 1/20 0.39
KAT6A Q92794 3/20 0.38
CD38 P28907 5/20 0.37
PARP2 Q9UGN5 1/20 0.36
PARP3 Q9Y6F1 1/20 0.36
AVPR2 P30518 1/20 0.36
OXTR P30559 1/20 0.36
AVPR1A P37288 1/20 0.36
TPH1 P17752 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4096687 0.77 TDO2 (0.47) MAPTRAB9AKDM4EALDH1A1GAA
SCHEMBL9956153 0.74 MYC (0.53) MAPTRAB9AKDM4EALDH1A1GAA
SCHEMBL5789460 0.73 ALDH1A1 (0.49) MAPTKDM4EALDH1A1GAANPC1
SCHEMBL16573945 0.72 MAPT (0.45) MAPTRAB9AKDM4EALDH1A1GAA
SCHEMBL28042578 0.72 NPC1 (0.41) MAPTRAB9AKDM4EALDH1A1GAA
SCHEMBL4848193 0.71 KAT6A (0.48) MAPTRAB9AKDM4EALDH1A1GAA
SCHEMBL27214503 0.70 ALDH1A1 (0.52) MAPTKDM4EALDH1A1GAAPARP1
SCHEMBL13078703 0.70 MAPT (0.52) MAPTRAB9AKDM4EALDH1A1GAA
SCHEMBL6459628 0.69 KAT6A (0.46) MAPTRAB9AKDM4EALDH1A1GAA
SCHEMBL16574135 0.67 TGFBR1 (0.45) MAPTRAB9AKDM4EALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090221546-A1 INHIBITORS OF FACTOR XA AND OTHER SERINE PROTEASES INVOLVED IN THE COAGULATION CASCADE PFIZER INC 2009-09-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090221546-A1 INHIBITORS OF FACTOR XA AND OTHER SERINE PROTEASES INVOLVED IN THE COAGULATION CASCADE F11, F2, TFPI MAPT 4776/4885RAB9A 2273/4885KDM4E 3770/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.